Answers are grounded in this paper and cite their sources.
Reviewing expanding liver transplant indications for non-HCC cancers, indicating evolving treatment options.
Liver transplantation (LT) is a life-saving procedure most well-known in the curative treatment of cirrhosis or end-stage liver disease. The approach is also well established for hepatocellular carcinoma (HCC) within Milan or other similar criteria. However, LT is increasingly utilized as the treatment for other primary and secondary liver cancers, including cholangiocarcinoma, colorectal cancer liver metastasis, neuroendocrine tumor, and angiosarcoma. We aim to review indications for LT for non-HCC hepatic malignancies.
No takes yet. Share an insight, caveat, or question.
Wehrle et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: